Using PRP and Cord Blood in Treatment of Covid -19

Aljazeera Hospital

Status: Unknown

Conditions: Virus

Treatments: Combination Product: stem cells

Study type: Interventional

Funder types: Other

Identifiers

NCT04393415

covid -19

Details and patient eligibility

About

covid - 19 is a critical viral infection that affects humans

Full description

Covid -19 pandemic started was declared in 2020

Enrollment: 100 estimated patients

Sex: All

Ages: 20 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with positive covid -19 and has symptoms and isolated in the hospital

Exclusion criteria

• patients with negative test for covid -19

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

100 participants in 3 patient groups

patients receiving LGF

Active Comparator group

Treatment:

Combination Product: stem cells

patients not receiving LGF nor PRP

No Intervention group

patients receiving Platelet rich plasma

Active Comparator group

Treatment:

Combination Product: stem cells